Last update:

Oncology & Cancer news

Oncology & Cancer

People who experience side effects from cranial radiation therapy may recover full neurocognitive function within months

A substantial number of patients with brain metastases who experience cognitive side effects following radiation therapy may fully regain cognitive function, according to a pooled analysis of three large, Phase III clinical ...

Oncology & Cancer

Radiopharmaceutical therapy offers promise for people with tough-to-treat meningioma brain tumors

A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, ...

Oncology & Cancer

What is CAR-T cell therapy? Oncologist explains

Roughly 635,000 new cases of lymphoma were diagnosed worldwide, according to the World Cancer Research Fund International's most recent report. Survival rates for aggressive lymphomas have improved significantly thanks to ...

Oncology & Cancer

Genetic mutations in HRAS, KRAS genes linked to childhood cancers

Hereditary changes in genes are often the cause of rare diseases. For example, disease-causing gene variants (PVs) in the HRAS gene cause Costello syndrome and PVs in the KRAS gene cause Noonan syndrome and cardio-facio-cutaneous ...

Oncology & Cancer

Treatment-free remission for chronic myeloid leukemia

Leukemias are cancers of the blood cells. Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the bone marrow, which produces blood cells. "Myelogenous" refers to the type of blood cells this leukemia affects. ...

Oncology & Cancer

Saving time with AI-generated treatment plans for breast cancer

Drawing in the organs of individual breast cancer patients and then creating precise radiation plans appears to be faster by using artificial intelligence (AI) models. That way, it remains just as reliable and accurate. It ...

Oncology & Cancer

AI could predict breast cancer risk via 'zombie cells'

Women worldwide could see better treatment with new AI technology, which enables better detection of damaged cells and more precisely predicts the risk of getting breast cancer, shows new research from the University of Copenhagen.

Medical research

Promising drug combo targets aggressive bladder cancers

A new study in mice by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) has identified a promising drug combination for the treatment of muscle-invasive bladder cancer. Rosiglitazone plus trametinib worked ...

Medications

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety, according to results of a phase two ...

Oncology & Cancer

How cancer cells harness energy to drive disease progression

Researchers have revealed crucial insights into how the Warburg effect causes the dedifferentiation of cancer cells through epigenetic reprogramming. This discovery potentially opens up new avenues for cancer treatments that ...

Oncology & Cancer

The key role of Galectin-3 in brain tumor development

A research group at the Department of Biochemistry and Molecular Biology of the University of Seville has made a significant advance by discovering the crucial role of the protein Galectin-3 in the progression of various ...

Oncology & Cancer

Gene expression and bioinformatics tools to optimize cancer therapy

In the field of biomedical research and genomics, the advancement of bioinformatics technologies and tools is opening new frontiers in the understanding of diseases and their diagnosis and treatment. In particular, differential ...

Oncology & Cancer

Scientists track 'doubling' in origin of cancer cells

Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that can lure cells down a hazardous path of duplicating their genome too many times, a hallmark of cancer ...

Oncology & Cancer

Turning a tumor's 'shield' into a weapon against itself

Tumor cells are "cunning," according to Peter Yingxiao Wang. They have a nefarious way of evading the human immune responses that fight back against these cancerous invaders. Tumor cells express programmed death-ligand 1 ...